Lung Cancer Europe Member Forums for Autumn

The first phase of the Lung Cancer Europe Member Forum has now wrapped up, with four sessions held between January and June 2026.

The Forum was created to give member organisations a regular space to share practical experience, compare approaches and learn from work happening in other countries.

Across the first four sessions, members shared experience on low-dose CT screening, return to work, patient navigation and peer support. Five presentations were given by member organisations, with between 8 and 18 people joining each session.

What members told us

We asked members for feedback before planning the next phase.

Of the nine people who responded:

  • 89% had attended at least one session

  • 67% had attended more than one

  • the meetings received an average rating of 4.38 out of 5 for how informative they were

  • 100% said they wanted to continue participating.

Members particularly valued hearing perspectives from other countries, meeting other organisations and exchanging practical ideas.

They also gave us clear suggestions for the next phase. These included keeping the combination of presentations and discussion, sharing topics and questions in advance, making sessions as practical as possible, and creating more opportunities for members to speak and exchange ideas.

What’s coming next

The Member Forum returns on 7 October 2026, with a session on grants, fundraising and sponsorship.

The programme currently planned for 2026 and 2027 includes:

December 2026
Supporting Volunteers & Advocates

February 2027
Patient Engagement & Digital Tools

April 2027
Communications that Reach Patients

June 2027
Working with Healthcare Professionals / Researchers

August to September 2027
Year in Review & Phase 3 Co-Design.

We’ll keep using member feedback to develop the Forum, with future sessions giving organisations more opportunities to share their own experience, practical tools and approaches from across Europe.

Next
Next

No Time to Lose: Integrated Rapid Referral Pathways for Lung Cancer